TGTX
#1003
TG Therapeutics, Inc. - Common Stock
56.7 1 USD
0.00%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-0.33%
Changement Mensuel
+17.61%
Evolution sur 6 mois
+97.25%
Changement Annuel
+77.66%
Clôture Précédente
56.9 0
Open
56.7 1
Low
56.7 1
High
56.7 1
Volume
121
Financials
- Market Capitalization 8.68 B
- Employee 399
- Founded 1993
- CEO Michael S Weiss
- Website www.tgtherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG000FVZQY1
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
20.05
ratio cours/chiffre d'affaires
10.98
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 977 |  CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 84.95 USD | 0.00% | +0.11% | +1.19% | +106.69% | 9.01 B USD | ||
| 980 |  ABVX Abivax SA - American Depositary Shares | 114.04 USD | +2.66% | -0.26% | -9.77% | +34.15% | 8.96 B USD | ||
| 1004 |  IBRX ImmunityBio, Inc. - Common Stock | 8.19 USD | +3.02% | -0.73% | +17.67% | +239.83% | 8.68 B USD | ||
| 1018 |  APGE Apogee Therapeutics, Inc. - Common Stock | 135.07 USD | -0.01% | +0.09% | +0.65% | +152.04% | 8.40 B USD |